Information  X 
Enter a valid email address
  Print          More announcements

Wednesday 14 April, 2021

JP Morgan Sec LLC

AON plc 8.3

RNS Number : 4817V
J.P. Morgan Securities LLC
14 April 2021
 

 Ap19

 

 

FORM   8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1.  KEY   INFORMATION

 

Nameofpersondealing (Note 1)

J.P. Morgan Securities LLC

Companydealtin

AON plc

Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate (Note 2)

US$0.01 ordinary shares

Date of dealing

 13 April 2021

 

2.  INTERESTS AND SHORT POSITIONS

 

(a)  Interests   and   short   positions   (following   dealing)   in   the   class   of   relevant   security   dealt   in   (Note   3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1)Relevantsecurities

6,485,944  2.87

2,030,832  0.90

(2) Derivatives (other than options)

1,775,029  0.78

37,973  0.02

(3)Optionsandagreementstopurchase/sell

 

303,100  0.13

Total

8,260,973  3.65

2,371,905  1.05

             

 

 

Ap20

 

 

1.  DEALINGS  (Note   4)

 

(a)  Purchases and sales

 

 

  Purchase/sale

 

Numberofrelevantsecurities

 

Priceperunit (USD)

 

  (Note 5)

Purchase(New Borrow)

 

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

Sales

19,500

 

1,025

 39

 39

 2

 2

 1

 2

 6,000

 21

 2

 100

 201

 6

 47

 32

 56

 2

 4

 200

 1

 297

 6

 6

 12

 2

 500

 5

 17,423

 2

 13

 15

 4

 5

 1

 1

 8

 2

 1

 1

 17

 26

 1

 10

 11

 2

 2

 1

 1

 262

 4

 1

 2

 27

 161

 300

 461

 

 1,025

 39

 2

 1,374

 102

 2,643

 6,000

 510

 200

 677

 200

 2

 411

 96

 100

 6

 8,619

 9,533

 1

 1

 11

 100

 461

N/A

 

237.7700  USD

238.3100  USD

238.3105  USD

238.6400  USD

238.6800  USD

238.7100  USD

238.8300  USD

238.9265  USD

238.9386  USD

239.0000  USD

239.0300  USD

239.0500  USD

239.0750  USD

239.0898  USD

239.1150  USD

239.1220  USD

239.1300  USD

239.1500  USD

239.1550  USD

239.1600  USD

239.1669  USD

239.2000  USD

239.2033  USD

239.2058  USD

239.2200  USD

239.2260  USD

239.2300  USD

239.2400  USD

239.2500  USD

239.2638  USD

239.2660  USD

239.2700  USD

239.2720  USD

239.2800  USD

239.2900  USD

239.2988  USD

239.3000  USD

239.3100  USD

239.3200  USD

239.3500  USD

239.3785  USD

239.3900  USD

239.4200  USD

239.4364  USD

239.4750  USD

239.4800  USD

239.4900  USD

239.5300  USD

239.5301  USD

239.5350  USD

239.5700  USD

239.5900  USD

239.6000  USD

239.6320  USD

239.7400  USD

239.8821  USD

 

237.7700  USD

238.3105  USD

238.6950  USD

238.7598  USD

238.8300  USD

238.9135  USD

238.9265  USD

238.9608  USD

239.0450  USD

239.0725  USD

239.0800  USD

239.0900  USD

239.1578  USD

239.1800  USD

239.1900  USD

239.2033  USD

239.2400  USD

239.2423  USD

239.2800  USD

239.2900  USD

239.4364  USD

239.5600  USD

239.8821  USD

 

(b)  Derivatives transactions (other than options transactions)

 

Productname,

e.g. CFD

Natureoftransaction

(Note 6)

Numberofrelevantsecurities

(Note 7)

Priceperunit

(USD)

(Note 5)

Equity Swap

Decrease Long

 

 

Increase Long

 

Increase Short

39

 461

 

 6,000

 

 6

238.3105  USD

239.8821  USD

 

238.9265  USD

 

239.2033  USD

 

 

 

 

(c)  Options transactions in respect of existing relevant securities

 

 

(i)  Writing, selling, purchasing or varying

 

Productname,

e.g. call option

Writing, selling,purchasing,varyingetc.

Numberofsecurities towhichtheoptionrelates (Note 7)

Exercise price (USD)

Type, e.g.American,Europeanetc.

Expiry date

Optionmoney paid/receivedperunit (Note 5)

Call Option

Writing

3,100

270.00 USD

American

17DEC21

6.90 USD

 

(ii)  Exercising

 

Productname,

e.g. call option

Numberofsecurities

Exercisepriceper unit (Note 5)

 

 

 

 

 

(d)  Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2.  OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other 

person relating to the voting rights of any relevant securities under any option referred to on this form or relating 

to   the   voting   rights   or   future   acquisition   or   disposal   of   any  relevant securities to which any derivative referred 

to on this form is referenced. If none, this should be stated.

 

  None

 

 

 

 

 

 

Is a Supplemental Form 8 attached?  (Note   9)    Yes

 

Dateofdisclosure

14 April 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If aconnectedEFM,nameofofferee/offerorwithwhichconnected

N/A

If aconnectedEFM,statenatureofconnection (Note 10)

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL   FORM 8

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.1 AND  RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

 

 

 

DETAILS   OF OPEN POSITIONS

 

(This   form   should   be   attached   to   Form   8.1(a)   & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

 

OPEN POSITIONS  (Note   1)

 

 

 

Productname,

e.g. call option

Written, orpurchased

Numberofrelevant securitiestowhichtheoptionorderivativerelates

Exercise price (Note 2) (USD)

Type, e.g.American,Europeanetc.

Expiry date

Call Option

Call Option

Call Option

Call Option

Call Option

Written

Written

Written

Written

Written

 

 

 

46,200

 71,700

 77,400

 104,700

3,100

270.00

270.00

270.00

270.00

270.00

American

American

American

American

American

17/12/2021

17/12/2021

17/12/2021

17/12/2021

17/12/2021

 

 

Notes

 

1.  Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.  For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rule 8 of the   Rules. If in doubt, consult the Panel.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEGPUAGCUPGGPC

a d v e r t i s e m e n t